Our patient had CM1, a nonfunctioning pituitary tumor, and normal GH and IGF-1 levels, raising the possibility of another underlying mechanism, perhaps a genetic predisposition, contributing to the concomitant occurrence of CM1 with pituitary and adrenal tumors and an adrenal myelolipoma. This evidence concerns the gene GH1 and adrenal gland neoplasm.